Darren Kelly Certa TherapeuticsAustralia

Darren is the CEO and Managing Director of Certa Therapeutics, bringing over 25 years of management and research expertise in the life sciences and biotech sector. Concurrent to this role, Darren is the Executive Chair and Founder of OccuRx, Venture partner (Entrepreneur in Residence) with Brandon Capital, a Board Director at the Centre for Eye Research Australia (CERA) and the Director Biomedical Research in the Department of Medicine, St Vincent’s Hospital Melbourne where his research expertise lies in progressing pre-clinical novel interventions and developing experimental models of cardiovascular disease.Darren has published over 200 manuscripts in the field of translational research and novel interventions, many of which have had a direct impact on human disease. In 2009, Darren was a recipient of the prestigious TJ Neale award for outstanding contribution to nephrology. Darren has a PhD in Translational Medicine from the University of Melbourne, and an Executive Diploma Business Administration.